Area of research
Molecular Biology · Biomedical Engineering · cancer · breast cancer drug design
Research interest
Research interests include Nanoplatforms for cancer theranostics, Extracellular vesicles in disease, Immunotherapy and Immune Responses, and Nanoparticle-Based Drug Delivery.
Harnessing Chlorella vulgaris-derived extracellular vesicles for potentiated cancer immunotherapy
CD4<sup>+</sup> Th Cell-Derived Extracellular Vesicles Orchestrate CD8<sup>+</sup> T Cells and Eosinophils to Enhance Anti-Tumor Immunity.
Bioengineering Platelets Presenting PD-L1, Galectin-9 and BTLA to Ameliorate Type 1 Diabetes.
Harnessing genetically engineered cell membrane-derived vesicles as biotherapeutics
Bioengineered Artificial Extracellular Vesicles Presenting PD-L1 and Gal-9 Ameliorate New-Onset Type 1 Diabetes
Bioengineered Artificial Extracellular Vesicles Presenting PD-L1 and Gal-9 Ameliorate New-Onset Type 1 Diabetes.
In situ immunomodulation of tumors with biosynthetic bacteria promote anti-tumor immunity
Harnessing enucleated cancer cells as Trojan horse cell vaccines
Engineered Cell Membrane Vesicles Expressing CD40 Alleviate System Lupus Nephritis by Intervening B Cell Activation.
Microneedle Patches Loaded with Nanovesicles for Glucose Transporter-Mediated Insulin Delivery
Engineered T cell extracellular vesicles displaying PD-1 boost anti-tumor immunity
Biosynthetic neoantigen displayed on bacteria derived vesicles elicit systemic antitumour immunity
Biosynthetic neoantigen displayed on bacteria derived vesicles elicit systemic antitumour immunity.
Bioorthogonal catalytic patch
Genetic engineering cellular vesicles expressing CD64 as checkpoint antibody carrier for cancer immunotherapy.
Polysaccharide from flammuliana velutipes improves colitis via regulation of colonic microbial dysbiosis and inflammatory responses
Engineered PD‐L1‐Expressing Platelets Reverse New‐Onset Type 1 Diabetes
Photothermal cancer immunotherapy by erythrocyte membrane-coated black phosphorus formulation
Surgical Tumor-Derived Personalized Photothermal Vaccine Formulation for Cancer Immunotherapy
Surgical Tumor-Derived Personalized Photothermal Vaccine Formulation for Cancer Immunotherapy.
Bioresponsive Protein Complex of aPD1 and aCD47 Antibodies for Enhanced Immunotherapy
In situ sprayed bioresponsive immunotherapeutic gel for post-surgical cancer treatment
In situ formed reactive oxygen species–responsive scaffold with gemcitabine and checkpoint inhibitor for combination therapy
Bacteria-Driven Hypoxia Targeting for Combined Biotherapy and Photothermal Therapy
Conjugation of haematopoietic stem cells and platelets decorated with anti-PD-1 antibodies augments anti-leukaemia efficacy
Engineering PD-1-Presenting Platelets for Cancer Immunotherapy
Shape-controlled synthesis of liquid metal nanodroplets for photothermal therapy
A Drug‐Self‐Gated Mesoporous Antitumor Nanoplatform Based on pH‐Sensitive Dynamic Covalent Bond
TPGS‐Functionalized Polydopamine‐Modified Mesoporous Silica as Drug Nanocarriers for Enhanced Lung Cancer Chemotherapy against Multidrug Resistance
Systematic investigation on the intracellular trafficking network of polymeric nanoparticles